Navigation Links
Study finds key protein for firing up central nervous system inflammation
Date:5/2/2013

HOUSTON Scientists have identified an influential link in a chain of events that leads to autoimmune inflammation of the central nervous system in a mouse model of multiple sclerosis (MS).

An international team of researchers led by scientists in The University of Texas MD Anderson Cancer Center Department of Immunology reported their results in an advance online publication in Nature Medicine.

The researchers spell out the pivotal role of Peli1 in the activation of immune cells called microglia that promote inflammation in the central nervous system in response to tissue damage or invasion by microbes.

"The major implication of discovering a signaling role for Peli1 in this animal model is that it might also be significant in the pathogenesis of MS," said senior author Shao-Cong Sun, Ph.D., professor in MD Anderson's Department of Immunology.

Microglia cells involved in multiple sclerosis

Sun and colleagues found that Peli1 is heavily expressed in microglial cells and promotes their activation and subsequent damaging immune response. Peli1 also protects that autoimmune reaction by initiating the destruction of a protein that otherwise would inhibit inflammation.

Microglia are known to be crucial to the initiation of MS, an immune system assault on nerve fibers called axons and on myelin, the protective sheath around the axons. They also were previously known to play a similar role in experimental autoimmune encephalomyelitis (EAE), an animal model of MS.

The precise mechanism of this autoimmune-stimulating effect has been unknown. Sun and colleagues fill an important gap with their Peli1 discovery.

Microglia sense tissue damage. They secrete chemokines and inflammatory cytokines in response, drawing infection-fighting T cells into the central nervous system, leading to inflammation.

Infections genetic overreaction that inflames

The authors note that microbi
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 02, 2015 Glidewell Laboratories, industry-leading ... today that the new issue of Chairside® magazine, ... and online. The digital edition of the latest ... past issues of the dental laboratory’s magazine, can ... smartphone platforms by visiting http://www.chairsidemagazine.com . , ...
(Date:6/2/2015)... 02, 2015 The Non-GMO Project ... products made according to rigorous best practices for ... produced in compliance with the Non-GMO Project Standard ... risk ingredients, facility inspections and an annual audit ... avoidance. , “Savoury Systems is and has always ...
(Date:6/2/2015)... 02, 2015 Mercy Health (formerly Catholic ... and Kentucky – has devoted the seventh of its ... skin cancer prevention. One in five Americans will get ... Health’s YouTube channel, a Mercy Health expert addresses these ... main causes of skin cancer? ,     What are ...
(Date:6/2/2015)... June 02, 2015 The Radiosurgery ... study from the RSSearch® Patient Registry evaluating the ... radiotherapy (SBRT) for the treatment of centrally located ... metastases. , The study, published in the ... ), included 111 patients with 114 centrally located ...
(Date:6/2/2015)... Dallas, TX (PRWEB) June 02, 2015 FDA ... to qualified Diet Doc patients after a satisfactory doctor consultation. ... on the market for several years and has the longest ... Working to block the enzyme that breaks down fats in ... diverting them through the intestinal system to be excreted through ...
Breaking Medicine News(10 mins):Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 2Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 3Health News:Savoury Systems International Receives Non-GMO Project Verification Continuing its Commitment to Provide Customers with Clean Label Ingredients 2Health News:Video provides helpful information about skin cancer prevention 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 3Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 2Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 3Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 4
... technology that was developed for an aerospace high-speed ... device for heart failure patients.(Logo: http://www.newscom.com/cgi-bin/prnh/20081007/38461LOGO )NASA,s ... advanced aerospace resin, named Langley Research Center,s Soluble ... to chemicals, and withstands extreme hot and cold ...
... Senate recently introduced legislation that would increase access to ... need for a physician,s referral or certification of the ... access is authorized, says the American Physical Therapy Association ... Therapists Act (S 950), introduced by Senators Blanche Lincoln ...
... Increased Case Volume Continue to Drive Revenue GrowthALISO VIEJO, Calif., ... (Nasdaq: CLRT ), a premier ... and the pharmaceutical industry, today reported $22.4 million in revenue ... increase as compared with $15.9 million for the same period ...
... a.m. Central Daylight Time. HOUSTON, May 6 Service Corporation International (NYSE: SCI ), ... Our consolidated financial statements can be found at the end of this press release. ... ... ...
... May 6 The Generic Animal Drug Alliance ... animal health industry interests, says that the recent ... illustrates the potential safety issues surrounding compounded drugs ... Food and Drug Administration (FDA) approved animal generic ...
... of the nation,s leading cardioelectrophysiologists, has joined The Mount Sinai Medical ... ... York, NY (Vocus)-- Vivek Y. Reddy, M.D., one of the nation,s ... as Director of Electrophysiology Laboratories. His appointment becomes effective July ...
Cached Medicine News:Health News:Cardiac Patients Take NASA Super Plastic to Heart 2Health News:Cardiac Patients Take NASA Super Plastic to Heart 3Health News:Senate Introduces Legislation to Increase Access to Physical Therapist Services 2Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 2Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 3Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 4Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 5Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 6Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 7Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 8Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 9Health News:Service Corporation International Announces First Quarter 2009 Financial Results 2Health News:Service Corporation International Announces First Quarter 2009 Financial Results 3Health News:Service Corporation International Announces First Quarter 2009 Financial Results 4Health News:Service Corporation International Announces First Quarter 2009 Financial Results 5Health News:Service Corporation International Announces First Quarter 2009 Financial Results 6Health News:Service Corporation International Announces First Quarter 2009 Financial Results 7Health News:Service Corporation International Announces First Quarter 2009 Financial Results 8Health News:Service Corporation International Announces First Quarter 2009 Financial Results 9Health News:Service Corporation International Announces First Quarter 2009 Financial Results 10Health News:Service Corporation International Announces First Quarter 2009 Financial Results 11Health News:Service Corporation International Announces First Quarter 2009 Financial Results 12Health News:Service Corporation International Announces First Quarter 2009 Financial Results 13Health News:Service Corporation International Announces First Quarter 2009 Financial Results 14Health News:Service Corporation International Announces First Quarter 2009 Financial Results 15Health News:Service Corporation International Announces First Quarter 2009 Financial Results 16Health News:Service Corporation International Announces First Quarter 2009 Financial Results 17Health News:Service Corporation International Announces First Quarter 2009 Financial Results 18Health News:Service Corporation International Announces First Quarter 2009 Financial Results 19Health News:Service Corporation International Announces First Quarter 2009 Financial Results 20Health News:Service Corporation International Announces First Quarter 2009 Financial Results 21Health News:Service Corporation International Announces First Quarter 2009 Financial Results 22Health News:GADA Points to Safety of FDA Approved Generics in Wake of Wellington Polo Horse Deaths from Compounded Drugs 2Health News:Vivek Y. Reddy, M.D., Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories 2Health News:Vivek Y. Reddy, M.D., Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories 3
(Date:6/1/2015)... Calif. , June 1, 2015   ... a biopharmaceutical company leading the discovery and development ... Kleanthis G. Xanthopoulos , Ph.D. has resigned ... a member of Regulus, Board of Directors, effective ... industry.  Paul Grint, M.D., who previously served as ...
(Date:6/1/2015)... 1, 2015 About Pressure ... large area and improve the quality life of patients ... devices play a significant role in inhibiting the growth ... need to turn or rotate an immobile patient by ... mattresses overlay, and specialty beds. These devices have the ...
(Date:6/1/2015)... , June 1, 2015 NEOVIA ... company engaged in the development and commercialization of ... that it has met with the U.S. Food ... the filing of an Investigational New Drug (IND) ... As a result of the meeting, Neovia has ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Neovia Oncology Announces First IND Meeting 2
... In Follow-up Period -, EXTON, Pa., Jan. ... injections have been completed in the pivotal,Phase III ... Therapy(TM) for the treatment of,nasolabial folds, or wrinkles ... follow-up period of the study., Isolagen also ...
... CLINICAL TRIAL RESULTS PUBLISHED IN THE JOURNAL OF ... 14 BioForm Medical,Inc. (Nasdaq: BFRM ) ... randomized, blinded comparative study of nasolabial fold,treatments reporting ... more effective than Restylane(R), the leading dermal filler,on ...
Cached Medicine Technology:Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies 2RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial 2RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial 3RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial 4
...
...
...
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Medicine Products: